Ke Xiao

Also affiliated with Medizinische Hochschule Hannover, Sichuan Provincial Architectural Design and Research Institute (China), China National Pharmaceutical Group Corporation (China), First Affiliated Hospital of Jiangxi Medical College, Kangmei Pharmaceutical (China), Kai Biotech (South Korea), First Affiliated Hospital of Nanchang University, Guangzhou Medical University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy”.

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy

European Heart Journal(2020)10.1093/eurheartj/ehaa519

N/A

0DataRank · unranked

120 citations

Ariana Foinquinos, Shambhabi Chatterjee, Jan Alphard Kleeberger, Ke Xiao, Heike Janssen‐Peters +17 more

Remodelling of adult cardiac tissue subjected to physiological and pathological mechanical load in vitro

Cardiovascular Research(2021)10.1093/cvr/cvab084

N/A

0DataRank · unranked

55 citations

Raquel Núñez-Toldrà, Ke Xiao, Worrapong Kit‐Anan, Saskia Mitzka, Richard J. Jabbour +6 more

Identification and Targeting of Regulators of SARS-CoV-2-Host Interactions in the Airway Epithelium

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.11.617898

N/A

0DataRank · unranked

1 citations

Heeju Noh, Lorenzo Tomassoni, Danting Cao, Yizhou Zhou, Ke Xiao +8 more